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Abstract  27 
Background: Protein ingestion before sleep augments post-exercise muscle protein synthesis 28 
during overnight recovery. Purpose: It is unknown whether post-exercise and pre-sleep 29 
protein consumption modulates post-prandial protein handling and myofibrillar protein 30 
synthetic responses the following morning. Methods: Sixteen healthy young (24±1 y) men 31 
performed unilateral resistance-type exercise (contralateral leg acting as a resting control) at 32 
20:00 h. Participants ingested 20 g protein immediately after exercise plus 60 g protein pre-33 
sleep (PRO group; n=8) or equivalent boluses of carbohydrate (CON; n=8). The subsequent 34 
morning participants received primed-continuous infusions of L-[ring-2H5]phenylalanine and 35 
L-[1-13C]leucine combined with ingestion of 20 g intrinsically L-[1-13C]phenylalanine and L-36 
[1-13C]leucine labelled protein to assess postprandial protein handling and myofibrillar 37 
protein synthesis in the rested and exercised leg in CON and PRO. Results: Exercise 38 
increased post-absorptive myofibrillar protein synthesis rates the subsequent day (P<0.001), 39 
with no differences between CON and PRO. Protein ingested in the morning increased 40 
myofibrillar protein synthesis in both the exercised- and rested-leg (P<0.01), with no 41 
differences between treatments. Myofibrillar protein bound L-[1-13C]phenylalanine 42 
enrichments were greater in the exercised (0.016±0.002 and 0.015±0.002 MPE in CON and 43 
PRO, respectively) versus rested (0.010±0.002 and 0.009±0.002 MPE in CON and PRO, 44 
respectively) leg (P<0.05), with no differences between treatments (P>0.05). Conclusions: 45 
The additive effects of resistance-type exercise and protein ingestion on myofibrillar protein 46 
synthesis persist for more than 12 h after exercise and are not modulated by protein 47 
consumption during acute post-exercise recovery. This work provides evidence of an 48 
extended window of opportunity where pre-sleep protein supplementation can be an effective 49 
nutrient timing strategy to optimize skeletal muscle reconditioning. 50 
 51 
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Introduction 52 
Resistance-type exercise training forms an effective interventional strategy to increase 53 
skeletal muscle mass and strength (e.g. 37). A single bout of resistance-type exercise 54 
increases both muscle protein synthesis and breakdown rates, albeit the latter to a lesser extent 55 
(2, 31). Though exercise improves net muscle protein balance, the balance remains negative 56 
in the absence of protein ingestion (2, 31). Dietary protein ingestion in close proximity to 57 
exercise further augments the exercise induced increase in muscle protein synthesis rate and 58 
inhibits exercise induced proteolysis, resulting in a positive post-exercise protein balance (3, 59 
5). This interaction between exercise and nutrition on the postprandial muscle protein 60 
synthetic response during recovery from exercise has been well-established, and forms a 61 
fundamental principle by which gains in muscle mass and strength are achieved in both an 62 
athletic and rehabilitative setting(e.g. 8, 41).  63 
Studies examining the synergy between exercise and nutrition generally administer protein 64 
immediately before (38, 39), during (1, 21) or immediately after (3, 23, 29, 32) exercise. 65 
Recently, we showed that protein administration prior to (33) or during (19) sleep can also 66 
augment overnight muscle protein synthesis rates. However, the influence of protein ingestion 67 
after exercise and/or before sleep on the myofibrillar protein synthetic response to subsequent 68 
meals has not yet been investigated. We reasoned that protein ingested immediately after 69 
exercise and/or prior to subsequent sleep would reduce the muscle protein synthetic response 70 
to the consumption of a meal-like amount of protein the following morning. Discovery of the 71 
existence (or absence) of such a negative feedback loop would be of key importance to our 72 
understanding of post-prandial protein handling and could have great relevance for nutritional 73 
intervention strategies in both a sports and rehabilitative setting. 74 
In the present study, we determined if protein ingestion immediately after a single bout of 75 
resistance-type exercise and prior to subsequent sleep modulates the postprandial myofibrillar 76 
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protein synthetic response to protein consumed the subsequent morning in both resting and 77 
exercised skeletal muscle tissue of healthy, young men. We hypothesized that ingesting large 78 
amounts of protein during acute and overnight recovery from resistance type exercise would 79 
modulate post-prandial protein handling and lower the post-prandial muscle protein synthetic 80 
response to protein feeding the following morning. We applied a unilateral one-legged 81 
exercise protocol (9) and combined the ingestion of specifically produced intrinsically L-[1-82 
13C]phenylalanine and L-[1-13C]leucine labelled dietary protein with continuous intravenous 83 
L-[ring-2H5] phenylalanine and L-[1-13C]leucine infusions, using a recently validated triple 84 
tracer approach (6). This allowed us to simultaneously assess post-absorptive and post-85 
prandial muscle protein synthesis rates as well as directly assess the accretion of the dietary 86 
protein derived amino acids into de novo myofibrillar protein in both resting and exercised 87 
skeletal muscle tissue. These data are the first to show that there is a window of opportunity 88 
during which protein feeding will augment post-exercise muscle protein synthesis rates 89 
without negative feedback inhibition of the post-prandial muscle protein synthetic response to 90 
protein consumed the following day. 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
 100 
 101 
 102 
 103 
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Methods 104 
 105 
Participants and ethical approval 106 
Sixteen healthy, young men (age: 24±1 y; body mass: 74.7±2.6 kg; BMI: 22.7±0.7 kg/m2) 107 
volunteered to participate in this study. Characteristics of the participants are presented in 108 
Table 1. Participants were recreationally active and engaged in exercise at least 2 times per 109 
week for ≥1 y. All participants were deemed healthy based on their response to a routine 110 
medical screening questionnaire. Participants were informed of the purpose of the study, 111 
experimental procedures, and all its potential risks prior to providing written consent to 112 
participate. Participants had no prior history of participating in stable isotope labelled amino 113 
acid tracer experiments. The study was approved by the Medical Ethics Committee of the 114 
Maastricht University Medical Centre+, Maastricht, the Netherlands and conformed to 115 
standards for the use of human participants in research as outlined in the sixth Declaration of 116 
Helsinki.  117 
 118 
Pretesting 119 
All participants underwent two pretesting sessions. Participants reported to the laboratory for 120 
familiarization with the exercise equipment and for determination of unilateral maximum 121 
strength as determined by their one repetition maximum (1RM) on leg extension and leg press 122 
machines for the right and left legs. In addition, body mass, height and body composition by 123 
dual-energy X-ray absorptiometry (Discovery A; Hologic Corp, Bedford, MA) were 124 
measured.  In a subsequent session, 10RM was confirmed by using 70% of the previously 125 
established 1RM and this was the exercise load that was used in the experimental trial. 126 
Subsequently, participants were randomly assigned and counterbalanced for leg strength to 127 
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either the protein (PRO; n=8) or carbohydrate (CON; n=8) treatments. All beverages used in 128 
the study were prepared in coded containers by an independent research assistant.  129 
 130 
Diet and physical activity control 131 
Participants were instructed to refrain from vigorous physical activity and to report their 132 
dietary intake in a food diary for two days prior to and on the first day of the experimental 133 
protocol. All participants consumed a standardized meal of the same composition (32±1 134 
kJ∙kg-1 body weight: providing 51 energy% (En%) carbohydrate, 33 En% fat, and 16 En% of 135 
protein) the evening prior to the experimental protocol.  136 
 137 
Experimental protocol 138 
An overview of the experimental protocol is shown in Figure 1. On day 1, participants were 139 
provided with standardized meals of identical composition (consisting of 57 Energy 140 
percentage (En%) carbohydrate, 13 En% protein, and 30 En% fat) to be consumed for 141 
breakfast, lunch, and dinner. Dinner was provided after the participants arrived at the 142 
laboratory at 17:00 h and was consumed under supervision. Subsequently, participants rested 143 
until 20:00 h when the exercise protocol was started. The exercise protocol consisted of 144 
unilateral resistance-type exercise performed for 4 sets × 10-12 repetitions to volitional 145 
fatigue with a load that corresponded to their previously established 10RM (~70% 1RM) on 146 
the horizontal leg press and leg extension machines (Technogym BV, Rotterdam, the 147 
Netherlands). There was a resting period of 2 min between each set and a 5 min rest between 148 
exercises. The contralateral leg did not perform resistance-type exercise and, as such, served 149 
as a rested control. To optimize muscle protein synthesis during acute recovery from exercise  150 
we provided subjects with 20 g whey protein immediately after cessation of exercise, which is 151 
currently advised in guidelines for optimal post-exercise recovery  (23, 44) (PRO; Bulk 152 
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powders Pure Whey Isolate 97, Sports Supplements Ltd, Colchester, Essex, UK) or 20 g 153 
carbohydrate (CON; 50% dextrose monohydrate, Avebe Food, Veendam, the Netherlands, 154 
50% maltodextrin, AppliChem GmbH, Darmstand, Germany) dissolved in 400 mL of water. 155 
At 23:00 h, the participants in the PRO group were provided with an additional 60 g of whey 156 
protein dissolved in 400 mL water to stimulate overnight muscle protein synthesis rates (33). 157 
The CON group received a 400 mL beverage containing 60 g carbohydrate instead. 158 
Afterwards, participants slept for 7.5 h within the laboratory. The next morning, participants 159 
were woken up at 07:00 h and a Teflon catheter was inserted into an antecubital vein for 160 
stable isotope infusion (Day 2; Figure 1). A second Teflon catheter was inserted into a dorsal 161 
hand vein of the contralateral arm and placed in a hot-box (60°C) for arterialized blood 162 
sampling. After baseline blood collection (t=-180 min), the phenylalanine, tyrosine, and 163 
leucine pools were primed with a single intravenous dose of L-[ring-2H5]phenylalanine (2 164 
µmol·kg-1), L-[3,5-2H2]tyrosine (0.615 μmol·kg-1), and L-[1-13C]leucine (4 µmol·kg-1). 165 
Subsequently, continuous L-[ring-2H5]phenylalanine (infusion rate: 0.05 µmol·kg-1·min-1), L-166 
[ring-2H2] tyrosine (0.15 μmol·kg-1·min-1), and L-[1-13C]leucine (0.10 µmol·kg-1·min-1) 167 
infusions were initiated and maintained throughout the protocol. To provide a reference value 168 
for postabsorptive myofibrillar protein synthesis rates (7, 10) a single muscle biopsy was 169 
collected from the exercised (EX-FAST) and rested (REST-FAST) legs after 180 min of 170 
infusion. Immediately after the muscle biopsies, participants ingested a single bolus of 20 g 171 
intrinsically L-[1-13C]phenylalanine and L-[1-13C]leucine-labelled whey protein dissolved in 172 
350 mL vanilla flavored water. Additional biopsies were collected at t=180 min for the 173 
measurement of postprandial muscle protein synthesis rates in the exercised (EX-FED) and 174 
non-exercised (REST-FED) legs. The biopsies were collected from the middle region of the 175 
vastus lateralis (15 cm above the patella) with a Bergström needle under local anesthesia. All 176 
biopsy samples were freed from any visible adipose tissue and blood, immediately frozen in 177 
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liquid nitrogen, and stored at –80˚C until subsequent analysis. Arterialized venous blood 178 
samples were drawn every 30 or 60 min during the post-absorptive and postprandial states 179 
and were processed as previously described (Figure 1) (7, 10).  180 
 181 
Intrinsically labelled whey protein 182 
Intrinsically L-[1-13C]phenylalanine and L-[1-13C]leucine labelled milk protein was obtained 183 
by a constant infusion of L-[1-13C]phenylalanine (455 µmol/min) and L-[1-13C]leucine (200 184 
µmol/min) maintained for 96 h in a lactating dairy cow (6, 30, 40). The milk was heated to 185 
50˚C and converted to skim milk before being microfiltrated using a membrane with a pore 186 
size of 1.4 μM at 50˚C to remove microbes. Subsequently, the skim milk was microfiltrated 187 
on a 0.2 μM pore size diameter membrane to separate the casein micelles from the soluble 188 
whey proteins at 55˚C. The whey proteins were collected and cooled. The soluble whey 189 
protein fraction was concentrated (~96% protein), sterile filtrated, and stored at room 190 
temperature prior to use. The L-[1-13C]phenylalanine and L-[1-13C]leucine enrichments in the 191 
whey protein were measured by gas chromatography mass spectrometry (Agilent 6890N GC 192 
coupled with a 5973 inert MDS; Little Falls, DE) after hydrolysis and averaged 36.1 MPE and 193 
8.9 MPE, respectively. The proteins met all chemical and bacteriologic specifications for 194 
human consumption. 195 
 196 
Plasma analyses  197 
Plasma glucose and insulin concentrations were analysed using commercially available kits 198 
(Glucose HK Gen.3, Roche, Ref: 05168791190, and Elecsys Insulin assay, Roche, Ref: 199 
12017547122, respectively). Mixed plasma proteins, plasma amino acid concentrations and 200 
enrichments were determined by gas chromatography-mass spectrometry analysis (Agilent 201 
6890N GC coupled with a 5973 inert MDS; Little Falls, DE) as previously described (7, 10) 202 
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 203 
Muscle analyses 204 
Myofibrillar protein enriched fractions were isolated as described in our previous work (6). 205 
Myofibrillar protein bound enrichments were determined by GC-MS analysis. To reduce the 206 
signal-to-noise ratio during GC-MS analysis at low tracer enrichments, the phenylalanine 207 
from the myofibrillar protein hydrolysates were enzymatically decarboxylated to β-208 
phenylethylamine (12) prior to tBDMS derivatization (35, 36). Enrichments of the protein 209 
bound samples were determined by selected ion monitoring for β-phenylethylamine-tBDMS 210 
mass to charge ratio at 183 (m+5) to 180 (m+2) and a single linear standard curve (to avoid 211 
slope influences on the measured TTR) from mixtures of known m+5 to m+2 ratios. To avoid 212 
saturation of the MS and eliminate bias due to any potential concentration dependencies (27), 213 
the split ratio was adjusted prior to the injection of each sample so that nearly equal amounts 214 
of phenylalanine were injected for all samples and standards. The remaining aliquot of 215 
purified amino acids were converted to their N(O,S)-ethoxycarbonyl ethyl esters derivatives 216 
to determine the L-[1-13C]phenylalanine and L-[1-13C]leucine labelling of the myofibrillar 217 
proteins by gas chromatography combustion-isotope ratio mass spectrometry analysis (GC-C-218 
IRMS; Trace GC Ultra, IRMS model MAT 253, Thermo Scientific, Bremen, Germany). The 219 
derivatized amino acids were separated on a 30m × 0.25mm × 0.25µm DB-5MS column 220 
(temperature program: 120˚C for 10 min; 3˚C min−1 ramp to 150˚C; 30˚C min−1 ramp to 221 
300˚C; hold for 5 min) prior to combustion. Standard regression curves were applied from a 222 
series of known standard enrichment values against the measured values to assess the linearity 223 
of the mass spectrometer and to account for any isotope fractionation which may have 224 
occurred during the analysis.  225 
Total RNA was isolated from 10-20 mg of frozen muscle tissue using Trizol Reagent (Life 226 
Technologies, Invitrogen) and quantitative RT-PCR was performed to determine skeletal 227 
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muscle mRNA expression of LAT1, CD98, SNAT2, PAT1, FOXO1, myostatin, MuRF1, and 228 
MAFBx as described in our previous work (42, 43). All genes of interest were labelled with 229 
the fluorescent reporter FAM (6-carboxyfluorescein). The thermal cycling conditions used 230 
were: 2 min at 50˚C, 10 min at 95˚C, followed by 50 cycles at 95˚C for 15 s and 60˚C for 1 231 
min. The housekeeping gene 18S was used as an internal control as we and others have used 232 
this as a reliable housekeeping gene in previous studies similar studies (13, 20, 42). Values of 233 
the target gene were normalized to Ct values of the internal controls and final results were 234 
calculated as relative expression against a standard curve. 235 
 236 
Calculations 237 
Whole-body amino acid kinetics were assessed in non-steady conditions by the ingestion of 238 
intrinsically L-[1-13C]phenylalanine labelled whey protein combined with the intravenous 239 
infusion of L-[ring-2H5]phenylalanine and L-[ring-3,5-2H2]tyrosine. Exogenous and 240 
endogenous phenylalanine rate of appearance (Ra), total rate of disappearance (Rd), and 241 
plasma availability of dietary protein-derived phenylalanine (the fraction of the dietary 242 
phenylalanine that appeared in systemic circulation, Pheplasma) were calculated using modified 243 
Steele equations (15, 28). 244 
The fractional synthetic rates (FSR) of myofibrillar protein were calculated using standard 245 
precursor-product methods by dividing the increment in L-[ring-2H5]phenylalanine, L-[1-246 
13C]leucine, or L-[1-13C]phenylalanine enrichment in the myofibrillar protein by the tracer 247 
enrichments of the plasma free precursor pool over time (7, 10). The single biopsy approach 248 
for the determination of the postabsorptive myofibrillar protein synthetic rates in the exercised 249 
and non-exercised legs was only used for the L-[ring-2H5]phenylalanine tracer as the modified 250 
prime with the L-[1-13C]leucine tracer (4 μmol/kg versus the more commonly used 7.6 251 
μmol/kg priming dose) did not allow for muscle protein labeling that was immediately linear 252 
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after initiating  the infusion and invalidated its use for the determination of postabsorptive 253 
muscle protein synthesis rates with the L-[1-13C]leucine tracer (7, 10). 254 
 255 
Statistics 256 
Differences in plasma amino acid, insulin and glucose concentrations, and tracer enrichments, 257 
and myofibrillar L-[1-13C]phenylalanine enrichments were tested by two-factor (treatment × 258 
time) repeated measures analysis of variance (ANOVA). Myofibrillar FSRs and muscle gene 259 
expression were analysed using a three-factor (treatment, protein ingestion and exercise 260 
conditions) ANOVA. When significant interaction effects were observed in the ANOVA, 261 
Bonferroni post-hoc tests were performed to locate these differences. Statistical significance 262 
was set at P<0.05. All calculations were performed using IBM SPSS Statistics Version 20. 263 
All data are expressed as means±SEM.  264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
 274 
 275 
 276 
 277 
 278 
 279 
 280 
 281 
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Results 282 
 283 
Participants’ characteristics 284 
Participants’ characteristics within the two experimental groups and their habitual dietary 285 
intakes are presented in Table 1. No differences in age, weight, height, BMI, body 286 
composition, strength or habitual diet were detected between groups. All subjects completed 287 
the required protocol for the single bout of one-legged resistance type exercise training, and 288 
consumed both the post-exercise and pre-sleep protein beverages without problem. In 289 
addition, all subjects reported being able to sleep well during the overnight stay in the 290 
laboratory.  291 
 292 
Plasma analyses  293 
Plasma glucose concentrations declined over time (P<0.001) during the experimental visit 294 
from ~4.9 to ~4.5 mmol.L-1 without any group differences (not shown). Plasma insulin 295 
concentrations (Figure 2A) showed a rapid and brief increase following protein ingestion (at 296 
t=0 min) in both groups up to 20-30 mU.L-1 after 30 min, before returning to baseline levels 297 
after 90 min (time effect; P<0.001). However, there was no effect of treatment (P=0.27) or 298 
any interaction (P=0.59) detected. Both plasma phenylalanine (Figure 2B) and leucine 299 
(Figure 2C) concentrations increased following protein ingestion in both groups (time effect; 300 
P<0.001) and remained above basal levels for 60 and 120 min, respectively. The time course 301 
of plasma L-[ring-2H5]phenylalanine (A), L-[1-13C]leucine (B) and L-[1-13C]phenylalanine 302 
(C) enrichments are illustrated in Figure 3. During the post-absorptive period, plasma L-303 
[ring-2H5]phenylalanine and L-[1-13C]leucine remained in steady-state at ~7-8 and ~5-6 MPE, 304 
respectively. Following protein ingestion (at t=0 min), plasma L-[ring-2H5]phenylalanine 305 
enrichments decreased for 60 min before returning to fasting, steady-state levels (time effect; 306 
P<0.001), while plasma L-[1-13C]leucine enrichments increased in response to protein 307 
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ingestion (time effect; P<0.001) and remained at an elevated steady state of ~8 MPE for the 308 
duration of the post-prandial period. No treatment effects were observed for plasma L-[ring-309 
2H5]phenylalanine and L-[1-13C]leucine enrichments, although an interaction effect was 310 
detected for L-[ring-2H5]phenylalanine (P<0.05) without any individual differences evident 311 
following post-hoc analysis. Following protein ingestion, plasma L-[1-13C]phenylalanine 312 
enrichments increased rapidly in both groups (time effect; P<0.001) from ~0 MPE to ~13-14 313 
MPE after 30 min in both groups and began declining thereafter, though remaining elevated 314 
above fasting levels for the entirety of the post-prandial period. However, no treatment or 315 
interaction effects were observed for plasma L-[1-13C]phenylalanine enrichments. 316 
 317 
Whole body phenylalanine kinetics 318 
Whole body phenylalanine kinetics are presented in Figure 4 (A-D). Exogenous 319 
phenylalanine rates of appearance (Ra) (i.e. the rate at which dietary protein-derived 320 
phenylalanine enters the circulation) (A) increased after protein ingestion (time effect; 321 
P<0.001) and to a similar extent in both groups. The amount of dietary protein-derived 322 
phenylalanine that appeared in the circulation over the 3-hour postprandial period was 323 
equivalent in both groups (56±1% vs 60±5% in CON and PRO, respectively; P=0.39). 324 
Endogenous phenylalanine Ra (i.e. the rate at which phenylalanine derived from whole body 325 
protein breakdown enters the circulation) (B) decreased after protein ingestion (time effect: 326 
P<0.001) with no differences observed between groups. Total phenylalanine Ra (C) and rates 327 
of disappearance (Rd) (D) increased after protein ingestion (time effect: both P<0.001). While 328 
total phenylalanine Ra was unaffected by nutritional intervention, a significant time × 329 
nutritional intervention effect was detected for Rd (P<0.05), with no individual effects located 330 
following post-hoc tests.  331 
 332 
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Skeletal muscle tracer analyses 333 
Mean postabsorptive and postprandial myofibrillar protein fractional synthetic rates (FSR) 334 
based on L-[ring-2H5]phenylalanine are presented in Figure 5. Based on the L-[ring-335 
2H5]phenylalanine tracer, post-absorptive myofibrillar FSRs in resting muscle did not differ 336 
between groups (0.021±0.001 and 0.026±0.004 %.h-1 in the CON and PRO groups, 337 
respectively; P>0.05) but were higher in exercised muscle (0.044±0.003 and 0.043±0.005 338 
%.h-1 in the CON and PRO, respectively) in both groups (main effect of exercise; P<0.001) 339 
without any interaction (P>0.05) or impact of the nutritional intervention (P>0.05). Based on 340 
the L-[ring-2H5]phenylalanine tracer, the ingestion of 20 g dietary protein stimulated 341 
myofibrillar FSR in resting (increased to 0.043±0.004 and 0.041±0.005 %.h-1 in CON and 342 
PRO, respectively) and exercised (increased to 0.060±0.006 and 0.058 %.h-1 in CON and 343 
PRO, respectively) muscle to a similar degree (main effect of protein ingestion; P<0.01) 344 
without any interaction or effect of the nutritional treatment evident (P>0.05). Due to higher 345 
post-absorptive FSR, exercised muscle retained higher myofibrillar FSR in the post-prandial 346 
state compared with resting muscle (main effect of exercise: P<0.001). Based on L-[1-347 
13C]leucine, post-prandial myofibrillar FSR was lower in resting (0.043±0.004 and 348 
0.041±0.005 %.h-1 for CON and PRO, respectively) compared with exercised (0.060±0.006 349 
and 0.058±0.005 %.h-1 for CON and PRO, respectively) muscle (main effect of exercise; 350 
P<0.001) without any differences detected between groups. 351 
Myofibrillar L-[1-13C]phenylalanine enrichments 3 h following the ingestion of 20 g 352 
intrinsically L-[1-13C]phenylalanine labelled whey protein are presented in Figure 6. 353 
Following protein ingestion, myofibrillar L-[1-13C]phenylalanine enrichments increased from 354 
background in resting (to 0.010±0.002 and 0.009±0.002 MPE in CON and PRO, respectively) 355 
and exercised (to 0.016±0.002 and 0.015±0.002 MPE in CON and PRO, respectively) muscle 356 
(main effect of protein ingestion; P<0.001) and by a greater degree in exercised compared 357 
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with resting muscle (P<0.001). However no effect of nutritional intervention or any 358 
interaction effects were detected. 359 
 360 
Gene expression 361 
The skeletal muscle mRNA expression of genes implicated in the regulation of intracellular 362 
amino acid transport and muscle protein breakdown are presented in Figure 7 (A-H). Muscle 363 
LAT1 mRNA expression (A) was increased with protein ingestion (P<0.001) exercise 364 
(P<0.05) and in the CON group compared with PRO (P<0.05).  Muscle PAT 1 mRNA 365 
expression (B) was higher in exercised compared with resting muscle (P<0.001) and 366 
decreased in response to protein ingestion in exercised muscle only (exercise × protein 367 
ingestion interaction; P<0.01). However, PAT1 expression did not differ between CON and 368 
PRO groups (P>0.05). Muscle SNAT2 mRNA expression (C) was higher in exercised muscle 369 
in the CON group only (exercise × nutritional intervention interaction; P<0.05), and 370 
decreased in response to protein ingestion in exercised muscle only (exercise × protein 371 
ingestion interaction; P<0.05). Muscle CD98 mRNA expression (D) was greater in exercised 372 
compared with resting muscle (P<0.01) and increased in response to protein ingestion 373 
(P<0.05) without any interaction or effect of nutritional intervention. Muscle myostatin 374 
mRNA expression (E) was lower in exercised compared with rested muscle (P<0.05) with the 375 
effect more profound in the PRO group (exercise × nutritional intervention interaction; 376 
P<0.05). Muscle MAFBx mRNA expression (F) was lower in exercised compared with 377 
resting muscle (P<0.001) and a three way interaction was observed (exercise × protein 378 
ingestion × nutritional intervention; P<0.05) such that expression increased in response to 379 
protein ingestion in the PRO group in exercised muscle, whereas expression decreased in 380 
response to protein ingestion in the CON group in resting muscle. Muscle MuRF1 mRNA 381 
expression (G) was lower in exercised compared with resting muscle in the fasting state only 382 
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(exercise × protein ingestion interaction; P<0.05). Muscle FOXO1 mRNA expression (H) 383 
increased in response to protein ingestion in resting muscle only (exercise × protein ingestion 384 
interaction; P<0.05).  385 
 386 
 387 
 388 
 389 
 390 
 391 
 392 
 393 
 394 
 395 
 396 
 397 
 398 
 399 
 400 
 401 
 402 
 403 
 404 
 405 
 406 
 407 
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Discussion 408 
The present work is the first to show that feeding large amounts of protein after a single bout 409 
of resistance-type exercise performed in the evening did not attenuate the post-prandial 410 
muscle protein synthetic response to protein consumed the following morning in either 411 
exercised or rested muscle tissue. Regardless of the ingestion of large amounts of protein 412 
immediately after exercise and prior to sleep the day before, the protein ingested the 413 
following morning was effectively digested and absorbed, stimulating post-postprandial 414 
muscle protein accretion, with the protein derived amino acids being used as precursors for de 415 
novo muscle protein synthesis. In addition, the stimulating effect of prior exercise on the 416 
myofibrillar protein synthetic response to protein ingestion persists the day after exercise was 417 
performed, regardless of whether large amounts of protein were consumed during acute and 418 
overnight recovery.   419 
Our previous work has established that 40 g protein ingestion before sleep represents an 420 
effective nutritional strategy to augment overnight muscle protein synthesis rates (33) and, 421 
consequently, the skeletal muscle adaptive response to prolonged resistance-type exercise 422 
training (37). Our current work offers the mechanistic underpinning of how pre-sleep protein 423 
supplementation acts as a nutrient timing strategy to facilitate skeletal muscle reconditioning 424 
(repair, remodelling, and/or muscle protein accretion). Specifically, the consumption of ample 425 
amounts of protein immediately after cessation of exercise (20 g) and prior to sleep (60 g) did 426 
not modulate digestion and absorption kinetics (Figure 4) or ‘desensitize’ the muscle protein 427 
synthetic response to protein ingested the following morning in either the exercised or non-428 
exercised leg (Figure 5). In support, we also demonstrated that the use of dietary protein 429 
derived amino acids for de novo postprandial muscle protein accretion did not differ between 430 
the PRO and CON groups in the previously exercised or non-exercised leg (Figure 6). As 431 
such, these data infer that exercise augments the muscle protein synthetic response to each 432 
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and every meal consumed within a given post-exercise time period, which would explain why 433 
pre-sleep protein feeding further augments muscle mass (and strength) gains during more 434 
prolonged resistance type exercise training [39].   435 
Contrary to exercise, pre-sleep protein feeding (i.e. when examining the non-exercised leg) 436 
did not modulate basal muscle protein synthesis rates determined the following morning. This 437 
is not surprising as the stimulatory effect of protein ingestion is temporary, lasting for approx. 438 
2-5 h (24). However, our work provides insight into the interactive effects of nutrition and 439 
exercise during late recovery, which is an area that, so far, has received little attention (11). 440 
Previous work has shown that the synergistic effects of exercise and protein ingestion on 441 
muscle protein synthesis rates occur immediately after exercise (4) and may persist for at least 442 
24 h during recovery from resistance-type exercise (11). Here, we show that protein ingested 443 
in the morning further increases muscle protein synthesis rates beyond the already elevated 444 
(post-absorptive) myofibrillar protein synthesis rates in the previously exercised leg, without 445 
any interference from prior ingestion of large amounts of protein during acute and overnight 446 
recovery. Moreover, we extend the time course of our previous work (29) by showing that 447 
exercise prior to protein ingestion allows for greater use of dietary protein derived amino 448 
acids for de novo muscle protein accretion for up to 17 h of post-exercise recovery (Figure 6). 449 
Collectively, these data provide evidence supporting the existence of a ‘window of anabolic 450 
opportunity’ for protein ingestion to further increase muscle protein synthesis rates during 451 
post-exercise recovery. This window of opportunity extends for at least 17 h of post-exercise 452 
recovery, where the ingestion of protein results in greater net muscle protein accretion. 453 
Feeding protein within this window likely supports the skeletal muscle adaptive response to 454 
training in a variety of populations or environments, resulting in greater net gains in muscle 455 
mass and/or strength.  456 
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In an effort to understand how protein before sleep may modulate the skeletal muscle adaptive 457 
response, we measured the mRNA abundance of amino acid transporters (LAT1, PAT1, 458 
SNAT2, CD98), markers of muscle proteolysis (FOXO1, MAFBx, MuRF1) (26) and a known 459 
key regulator of skeletal muscle mass (myostatin) (Figure 7) (22, 25). We extend on previous 460 
findings (14, 16-18) by demonstrating that the co-ordinated increase in gene expression of the 461 
amino acid transporters induced by resistance-type exercise persists the day after exercise. 462 
This was most evident in the contraction sensitive transporter PAT1 (16) which, in contrast, 463 
seemed remarkably resistant to any synergistic effects of nutritional stimuli. It is therefore 464 
likely that the prolonged elevations in muscle protein synthesis induced by resistance-type 465 
exercise (Figure 5) are supported by an increased intracellular availability of amino acids due 466 
to increased muscle amino acid uptake. Acute protein ingestion also led to a general increase 467 
in amino acid transporter expression, most notably that of LAT1. This is in line with previous 468 
findings (14, 16-18) and consistent with the role of LAT1 as a leucine specific amino acid 469 
transporter. However, LAT1 expression was greater in fasting muscle in response to protein 470 
ingestion in the CON group. It may be speculated that this result is serving as a compensatory 471 
mechanism to scavenge limited amino acid supply for transport into skeletal muscle tissue in 472 
the CON condition. Worthy of comment, it has been shown that the muscle protein synthetic 473 
response to protein ingestion generally subsides after 2-4 h (24) which would argue against 474 
the present observation of a far more sustained rise in amino acid transporter expression 475 
playing a strong modulatory role in the prolonged regulation of post-prandial muscle protein 476 
metabolism. Irrespective, it should be acknowledged that we did not measure protein levels or 477 
subcellular location of the amino acid transporters, and therefore their exact role(s) towards 478 
modulating the postprandial muscle protein synthetic response remains to be established, but 479 
will require carefully designed and specific future experiments. 480 
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We revealed an additional novel finding concerning the regulation of muscle myostatin gene 481 
expression. Myostatin gene expression was reduced in exercised muscle when protein was 482 
ingested during acute and overnight post-exercise recovery. This finding seems to be in line 483 
with the concept that low myostatin expression facilitates an anabolic environment (34), 484 
which our data suggest persists the day after exercise and is augmented by increased protein 485 
intake in the recovery period. Although exercise led to a general decrease in the expression of 486 
the atrogenes the subsequent day, presumably supporting muscle anabolism, this was not 487 
modulated by post-exercise nutrition. 488 
In conclusion, the consumption of large amounts of protein immediately after exercise and 489 
before sleep does not modulate dietary protein digestion and absorption kinetics or 490 
postprandial myofibrillar protein synthesis rates to the subsequent morning protein meal with 491 
or without prior exercise in healthy, young males. Our work provides insight into the 492 
effectiveness of night-time protein supplementation as an effective nutrient timing strategy to 493 
augment skeletal muscle reconditioning during prolonged resistance-type exercise training. 494 
 495 
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FIGURE LEGENDS 648 
 649 
Figure 1. Schematic of the experimental protocol.  650 
On Day 1, participants ingested a standardized meal and performed unilateral resistance 651 
exercise. Participants ingested either whey (PRO group; n=8) or carbohydrate (CON group; 652 
n=8) immediately after exercise and prior to sleep. On Day 2, all participants were roused 653 
from sleep, received primed continuous IV infusions, and ingested 20 g of intrinsically 654 
labeled whey protein. The drink can represents labeled protein ingestion. Asterisks indicate 655 
blood samples, and double upward arrows indicate bilateral biopsies were collected at 656 
corresponding time points representing the exercise (EX) and non-exercise (REST) legs. 657 
 658 
Figure 2 Mean (±SEM) plasma insulin (A), phenylalanine (B) and leucine (C) concentrations 659 
during a stable isotope experimental test day in the morning after overnight recovery from a 660 
unilateral bout of resistance-type exercise that was performed the evening before with (PRO; 661 
n=8) or without (CON; n=8) dietary protein consumed immediately after exercise (20 g) and 662 
prior to subsequent sleep (60 g). The vertical line on each graph indicates the transition from 663 
fasting to fed conditions via the consumption of 20 g dietary protein in all subjects. Data were 664 
analysed with a two-way repeated measures ANOVA with Bonferonni post hoc tests applied 665 
to locate individual differences: A, B and C all showed significant time effects (P<0.001) and 666 
* indicates values significantly different compared to ‘0’. No treatment or interaction effects 667 
were detected. 668 
 669 
Figure 3 Mean (±SEM) plasma L-[ring-2H5]phenylalanine (A; intravenously infused tracer 670 
only), L-[1-13C]leucine (B; intravenously infused and ingested within the intrinsically labelled 671 
dietary protein) and  L-[1-13C]phenylalanine (C; ingested within the intrinsically labelled 672 
 
 
dietary protein only) enrichments during a stable isotope experimental test day in the morning 673 
after overnight recovery from a unilateral bout of resistance-type exercise that was performed 674 
the evening before with (PRO; n=8) or without (CON; n=8) dietary protein consumed 675 
immediately after exercise  (20 g) and prior to subsequent sleep (60 g). The vertical line on 676 
each graph indicates the transition from fasting to fed conditions via the consumption of 20 g 677 
intrinsically labelled dietary protein in all subjects. Data were analysed with a two-way 678 
repeated measures ANOVA with Bonferonni post hoc tests applied to locate individual 679 
differences: A, B and C all showed significant time effects (P<0.001) and * indicates values 680 
significantly different compared to ‘0’. A significant interaction was detected for A (P<0.05), 681 
but no individual differences were observed. No treatment or interaction effects were detected 682 
for B or C. 683 
 684 
Figure 4 Mean (±SEM) whole body phenylalanine kinetics (A: exogenous rate of appearance 685 
[Ra] phenylalanine. B: Endogenous Ra phenylalanine. C: Total Ra phenylalanine. D: Total rate 686 
of disappearance [Rd] phenylalanine) during a stable isotope experimental test day in the 687 
morning after overnight recovery from a unilateral bout of resistance-type exercise that was 688 
performed the evening before with (PRO; n=8) or without (CON; n=8) dietary protein 689 
consumed immediately after exercise (20 g) and prior to subsequent sleep (60 g). The vertical 690 
line on each graph indicates the transition from fasting to fed conditions via the consumption 691 
of 20 g dietary protein in all subjects. Data were analysed with a two-way repeated measures 692 
ANOVA with Bonferonni post hoc tests applied to locate individual differences: A, B, C and 693 
D all showed significant time effects (P<0.001).  D also showed a significant time × treatment 694 
interaction (P<0.05) though no individual differences were detected. 695 
 696 
 
 
Figure 5 Mean (±SEM) post-absorptive (fast) and post-prandial (fed; ingestion of 20 g dietary 697 
protein) fractional myofibrillar protein synthesis rates (FSR) calculated from L-[ring-698 
2H5]phenylalanine during a stable isotope experimental test day in the morning after overnight 699 
recovery from a unilateral bout of resistance-type exercise that was performed the evening 700 
before with (PRO; n=8) or without (CON; n=8) dietary protein consumed immediately after 701 
exercise  (20 g) and prior to subsequent sleep (60 g). Data were analysed with a three-way 702 
(treatment, protein ingestion and exercise conditions) repeated measures ANOVA with 703 
Bonferonni post hoc tests applied to locate individual differences: significant main effects of 704 
protein ingestion (P<0.01) and exercise (P<0.001) were detected with no effect of nutritional 705 
intervention or any interactions. † indicates value significantly different compared with 706 
corresponding fasting value. # indicates value significantly different compared with 707 
corresponding resting value. 708 
 709 
Figure 6 Mean (±SEM) delta myofibrillar protein enrichment (MPE) of L-[1-710 
13C]phenylalanine 3 h after the ingestion of 20 g intrinsically L-[1-13C]phenylalanine labelled 711 
protein the morning after overnight recovery from a unilateral bout of resistance-type exercise 712 
that was performed the evening before with (PRO; n=8) or without (CON; n=8) dietary 713 
protein consumed immediately after exercise (20 g) and prior to subsequent sleep (60 g). Data 714 
were analysed with a two-way repeated measures ANOVA with Bonferonni post hoc tests 715 
applied to locate individual differences: significant main effect of exercise (P<0.001) with no 716 
effect of nutritional intervention or any interaction. # indicates value significantly different 717 
compared with corresponding resting value. 718 
 719 
Figure 7 Mean (±SEM) skeletal muscle mRNA expression of LAT1 (A), PAT1 (B), SNAT2 720 
(C), CD98 (D), myostatin (E), MAFBx (F), MuRF1 (G) and FOXO1 (H) in the post-721 
 
 
absorptive (fast) and post-prandial (fed; 3 h following ingestion of 20 g dietary protein) state 722 
the morning after an evening bout of one-legged resistance-type exercise in the previously 723 
exercised (EX) and rested (REST) muscle of two groups of healthy young men who 724 
previously had (PRO; n=8) or had not (CON; n=8) consumed post exercise (20 g) and pre-725 
sleep (60 g) dietary protein. Data were analysed with a three-way (treatment, protein ingestion 726 
and exercise conditions) repeated measures ANOVA with Bonferonni post hoc tests applied 727 
to locate individual differences: A: Significant effect of protein ingestion (P<0.001), exercise 728 
(P<0.05) and nutritional intervention (P<0.05). B: Significant effect of exercise (P<0.001) 729 
and exercise × protein ingestion interaction (P<0.01). C: Significant exercise × nutritional 730 
intervention interaction (P<0.01) and exercise × protein ingestion interaction (P<0.05). D: 731 
Significant effect of protein ingestion (P<0.05) and exercise (P<0.01). E: Significant effect of 732 
exercise (P<0.05) and exercise × nutritional intervention interaction (P<0.05). F: Significant 733 
effect of exercise (P<0.001) and exercise × protein ingestion × nutritional intervention 734 
interaction (P<0.05). G: Significant exercise × protein ingestion interaction (P<0.05). * 735 
denotes significantly different from corresponding CON value; † denotes significantly 736 
different compared with corresponding fasting value; # denotes significantly different 737 
compared with corresponding resting value. 738 
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Table 1. Participants’ characteristics 747 
 748 
Variable CON group (n=8) PRO group (n=8) Significance
Age (y) 25±2 23±1 NS 
Height (m) 1.81±0.02 1.82±0.02 NS 
Body mass (kg) 76.8±3.9 72.6±3.5 NS 
BMI (kg/m2) 23.6±1.2 21.9±0.7 NS 
Whole body lean mass (kg) 63.1±3.1 59.9±2.8 NS 
Body fat (%) 14.0±1.6 13.4±0.8 NS 
Single leg 1-RM leg extension [left] (kg) 66±6 63±6 NS 
Single leg 1-RM leg extension [right] (kg) 68±5 62±4 NS 
Single leg 1-RM leg press [left] (kg) 109±8 103±8 NS 
Single leg 1-RM leg press [right] (kg) 113±7 104±8 NS 
Habitual energy intake (MJ.d-1) 12.8±1.8 11.5±1.1 NS 
Habitual protein intake (g.d-1) 135±24 115±13 NS 
Habitual protein intake (g.kg-1.d-1) 1.73±0.26 1.52±0.15 NS 
Values represent means±SEM. NS: non-significant. g.kg-1.d-1: grams per kilogram body mass 749 
per day. 750 
Figure 1 
 
 
 
 
L-[ring-
2
H5]phenylalanine, L-[ring-
2
H2]tyrosine, & L-[1-
13
C]leucine IV infusion 
Blood 
Biopsy 
Minutes -180 0 
Protein  
intake 
120 60 180 
* 
-120 -60 
* * * * * * * * 
Unilateral 
Exercise 
Time (h) 8.00 9.00 10.00 11.00 14.00 12.00 13.00 
Day 2 
Day 1 Sleep 
Time (h) 
PRO group 
17.00 20.00 21.00 7.00 23.00 
20 g whey intrinsically labeled with L-
[1-
13
C]phenylalanine & L-[1-
13
C]leucine 
CON group 
Mixed meal  
Mixed meal 
20 g whey 
20 g CHO 
60 g whey 
60 g CHO 
Figure 2 
 
 
0
10
20
30
40
A CON
PRO
*
*
Pla
sm
a i
ns
uli
n (
mU
. L-
1 )
40
60
80
100
B * *
Pla
sm
a p
he
ny
lal
an
ine
 (?
mo
l. L
-1
)
-180 -120 -60 0 60 120 1800
200
400
600
C
* *
*
*
Pla
sm
a l
eu
cin
e (
? m
ol.
L-1
)
 
 
 
Figure 3 
 
 
 
0
2
4
6
8
10 A
CON
PRO
**
Pla
sm
a L
-[ri
ng
-2 H
5] 
ph
en
yla
nin
e (
MP
E)
0
2
4
6
8
10 B ** * * *
Pla
sm
a L
-[1
-13
C]
 le
uc
ine
 (M
PE
)
-120 -60 0 60 120 1800
5
10
15
20 C
**
* *
*
Pla
sm
a L
-[1
-13
C]
 ph
en
yla
nin
e (
MP
E)
 
 
 
 
 
 
Figure 4 
 
 
 
0.0
0.1
0.2
0.3
0.4 A
E
xo
ge
no
us
 R
a 
ph
en
yl
al
an
in
e 
(? m
ol
. k
g-
1.
m
in
-1
)
0.0
0.2
0.4
0.6
0.8
1.0 B
E
nd
og
en
ou
s 
R
a 
ph
en
yl
al
an
in
e 
(?
m
ol
. k
g-
1.
m
in
-1
)
-120 -60 0 60 120 180
0.0
0.2
0.4
0.6
0.8
1.0
1.2 C
Time (min)
To
ta
l R
a 
ph
en
yl
al
an
in
e 
(?
m
ol
. k
g-
1.
m
in
-1
)
-120 -60 0 60 120 180
0.0
0.2
0.4
0.6
0.8
1.0
1.2 D
CON
PRO
Time (min)
To
ta
l R
d  
ph
en
yl
al
an
in
e 
(?
m
ol
. k
g-
1.
m
in
-1
)
 
 
 
 
 
 
Figure 5 
 
 
 
 
REST-FAST REST-FED EX-FAST EX-FED
0.00
0.02
0.04
0.06
0.08 CON
PRO
#† †
† †
#
#
#
My
ofi
bri
lla
r F
SR
 (%
. h-
1 )
 
 
 
 
 
 
 
Figure 6 
 
 
 
REST EXERCISE
0.000
0.005
0.010
0.015
0.020 #CON
PRO #
My
ofi
bri
lla
r e
nri
ch
me
nt 
(M
PE
)
 
 
 
 
 
 
 
 
Figure 7 
 
 
0
2
4
6
*
*
#
†
†
#
*
†
†
A
LA
T1
 (r
el
at
iv
e 
ex
pr
es
si
on
)
0.0
0.5
1.0
1.5
2.0
2.5
#
†
†
#
#
#
#
B
P
A
T1
 (r
el
at
iv
e 
ex
pr
es
si
on
)
0.0
0.5
1.0
1.5
2.0
†
†
# #
C
S
N
A
T2
 (r
el
at
iv
e 
ex
pr
es
si
on
)
0.0
0.5
1.0
1.5
#
#
# #
†
†
† †
D
C
D
98
 (r
el
at
iv
e 
ex
pr
es
si
on
)
REST-FAST REST-FED EX-FAST EX-FED
0.0
0.5
1.0
1.5
2.0
2.5
#
#
E
M
yo
st
at
in
 (r
el
at
iv
e 
ex
pr
es
si
on
)
REST-FAST REST-FED EX-FAST EX-FED
0
1
2
3
4
#
††
## #
†
F
M
A
FB
x 
(r
el
at
iv
e 
ex
pr
es
si
on
)
REST-FAST REST-FED EX-FAST EX-FED
0
1
2
3
4
# #
G
M
uR
F1
 (r
el
at
iv
e 
ex
pr
es
si
on
)
REST-FAST REST-FED EX-FAST EX-FED
0.0
0.5
1.0
1.5
2.0
2.5
CON
PRO
†
†
H
FO
X
O
1 
(r
el
at
iv
e 
ex
pr
es
si
on
)
 
 
 
 
 
 
 
 
 
